在瘤进展过程中,Kras-依赖的普遍转录的异常积累使得癌细胞依赖PAF1表达
Xinhong Liu1, Xiangzheng Liu1, Yingxue Du2
1State Key Laboratory of Molecular Oncology, SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, School of Medicine, Tsinghua University, Beijing 100084, China.
Cell reports
|August 12, 2023
概括
通过保持基因组稳定性,RNA聚合酶II相关因子1复合体 (PAF1C) 对于胰腺癌细胞生存至关重要. 在胰腺管腺癌 (PDAC) 中PAF1C的损失导致DNA损伤和细胞死亡,突出显示了潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 基因组学就是基因组学.
背景情况:
- KRAS突变在癌症中普遍存在,特别是胰腺管道腺癌 (PDAC),这是最致命的形式.
- 突变KRAS通过复杂的细胞机制驱动瘤发生.
- 了解癌细胞对特定因素的依赖性对于治疗开发至关重要.
研究的目的:
- 研究RNA聚合酶II相关因子1复合体 (PAF1C) 在PDAC存活中的作用.
- 阐明突变KRAS信号影响癌细胞生物学的机制.
- 为了确定KRAS驱动的癌症的潜在漏洞.
主要方法:
- 在PDAC和正常的胰腺细胞中进行细胞活力测试.
- 对增强器RNAs (eRNAs) 和促进器上游转录 (PROMPTs) 的分析.
- 评估基因组稳定性,R环形成和DNA损伤.
- 研究由突变KRAS驱动的转录调节.
主要成果:
- 特别需要PAF1C来维持PDAC细胞的存活,而不是正常细胞.
- PAF1C抑制了由突变KRAS驱动的eRNA和PROMPTs的过度积累.
- 失去PAF1C会导致癌细胞中普遍的转录积累,R环形成和DNA损伤.
- 通过KRAS信号的全球转录性过活化会对PAF1C产生特定的依赖.
结论:
- 通过调节异常转录,PAF1C是维持PDAC基因组稳定的关键因素.
- 这项研究揭示了一种机制,将突变KRAS驱动的转录性过活化与PAF1C的依赖联系起来.
- 向PAF1C可能是治疗KRAS突变胰腺癌的一个有希望的策略.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


